Published in J Biol Chem on May 31, 1996
Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res (1998) 3.11
Characterization of emerging European-like porcine reproductive and respiratory syndrome virus isolates in the United States. J Virol (2004) 1.68
A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci U S A (1997) 1.55
Transcription regulatory complexes bind the human T-cell leukemia virus 5' and 3' long terminal repeats to control gene expression. Mol Cell Biol (2004) 1.09
A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression. J Virol (2004) 1.07
External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator. Proc Natl Acad Sci U S A (2002) 0.94
An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression. J Virol (1998) 0.90
Sequence analysis of porcine endogenous retrovirus long terminal repeats and identification of transcriptional regulatory regions. J Virol (2003) 0.88
cis-Acting inhibitory elements within the pol-env region of human T-cell leukemia virus type 1 possibly involved in viral persistence. J Virol (1997) 0.84
HUB1, a novel Krüppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expression. Nucleic Acids Res (1997) 0.82
The HTLV-1 Tax oncoprotein represses Ku80 gene expression. Virology (2011) 0.81
Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites. Sci Rep (2017) 0.75
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70
The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem (1984) 4.68
Mechanism of interaction between Ku protein and DNA. J Biol Chem (1986) 4.22
Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol (1999) 2.96
Purification and some properties of Clostridium botulinum type-E toxin. Biochim Biophys Acta (1968) 2.87
Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome. J Biol Chem (1984) 2.81
Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem (1986) 2.79
Purification and characterization of two components of botulinum C2 toxin. Infect Immun (1980) 2.74
Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol (1987) 2.71
Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest (1981) 2.68
The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem (1997) 2.59
Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem (1997) 2.51
Quantitative assessment of the efficacy of amorphous calcium phosphate/methacrylate composites in remineralizing caries-like lesions artificially produced in bovine enamel. J Dent Res (1996) 2.49
Purification and some properties of progenitor toxins of Clostridium botulinum type B. Infect Immun (1974) 2.48
Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem (1997) 2.32
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol (1991) 2.27
Molecular construction of Clostridium botulinum type A toxins. Infect Immun (1975) 2.22
Nucleotide sequence of the staphylocoagulase gene: its unique COOH-terminal 8 tandem repeats. J Biochem (1987) 2.21
Purification of Clostridium botuliunum type F progenitor toxin. Appl Microbiol (1974) 2.16
The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum (1983) 2.09
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis (2010) 2.04
Clostridium botulinum toxins. Pharmacol Ther (1982) 2.03
Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med (1991) 2.03
DNA-dependent protein kinase (Ku protein-p350 complex) assembles on double-stranded DNA. Proc Natl Acad Sci U S A (1994) 2.01
A new class of microtubule-associated proteins in plants. Nat Cell Biol (2000) 2.00
K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci U S A (1990) 1.99
Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties. Infect Immun (1977) 1.92
Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet (1994) 1.91
Rapid bioassay for Clostridium botulinum type-E toxins by intravenous injection into mice. Jpn J Med Sci Biol (1968) 1.88
Significance of 12S toxin of Clostridium botulinum type E. J Bacteriol (1969) 1.87
Purification and some properties of Aeromonas hydrophila hemolysin. Infect Immun (1984) 1.84
Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell (1984) 1.80
Laparoscopic partial hepatectomy and left lateral segmentectomy: technique and results of a clinical series. Surgery (1996) 1.79
Evidence that botulinum C2 toxin has two dissimilar components. Infect Immun (1980) 1.77
Ku polypeptides synthesized in vitro assemble into complexes which recognize ends of double-stranded DNA. J Biol Chem (1992) 1.75
Oral toxicities of Clostridium botulinum toxins in response to molecular size. Infect Immun (1977) 1.75
BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res (1998) 1.74
Simplified method for purification of Clostridium perfringens type A enterotoxin. Appl Microbiol (1973) 1.71
Mobile intracardiac calcinosis: a new risk of thromboembolism in patients with haemodialysed end stage renal disease. Heart (1999) 1.70
A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology (1996) 1.70
Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol (1999) 1.69
Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes. Infect Immun (1980) 1.67
Cutting edge: absence of expression of RAG1 in peritoneal B-1 cells detected by knocking into RAG1 locus with green fluorescent protein gene. J Immunol (1999) 1.67
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med (2000) 1.64
An outbreak of visceral larva migrans due to Ascaris suum in Kyushu, Japan. Lancet (1996) 1.62
High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol (2003) 1.61
The amino acid sequence of the procoagulant- and prothrombin-binding domain isolated from staphylocoagulase. J Biol Chem (1986) 1.60
Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. J Neurobiol (1996) 1.60
Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins. Infect Immun (1984) 1.59
Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori. J Gastroenterol (1996) 1.58
Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res (1991) 1.56
Structure and sequence of the human c-sis/platelet-derived growth factor 2 (SIS/PDGF2) transcriptional unit. Proc Natl Acad Sci U S A (1986) 1.56
Setting reactions and compressive strengths of calcium phosphate cements. J Dent Res (1990) 1.56
Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts. Oncogene (1999) 1.55
Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol (1996) 1.53
Diagnosis of a tear of the tibiofibular syndesmosis. The role of arthroscopy of the ankle. J Bone Joint Surg Br (2003) 1.51
Rotational acetabular osteotomy for severe dysplasia of the hip with a false acetabulum. J Bone Joint Surg Br (1996) 1.51
Botulinal toxins and the problem of nomenclature of simple toxins. Bacteriol Rev (1971) 1.51
Leukaemia of novel gastrointestinal T-lymphocyte population infected with HTLV-I. Lancet (1991) 1.48
Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc Natl Acad Sci U S A (2001) 1.48
Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect Immun (1977) 1.48
Nucleotide and deduced amino acid sequences of staphylocoagulase gene from Staphylococcus aureus strain 213. Nucleic Acids Res (1989) 1.48
Molecular construction of Clostridium botulinum type F progenitor toxin. Appl Microbiol (1975) 1.48
Collecting duct carcinoma with long survival treated by partial nephrectomy. Int J Urol (2001) 1.48
Physical and functional interactions of Doc2 and Munc13 in Ca2+-dependent exocytotic machinery. J Biol Chem (1997) 1.46
Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry (1995) 1.43
Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography. Jpn J Med Sci Biol (1974) 1.43
Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene (2006) 1.43
Prevalence of migraine in Japan: a nationwide survey. Cephalalgia (1997) 1.43
Clinical application of the perineal scan: prepartum screening for cord presentation. Am J Obstet Gynecol (1986) 1.42
Favorable strategy for the ostial lesion of the left anterior descending coronary artery: influence on narrowing of circumflex coronary artery. Cathet Cardiovasc Diagn (1998) 1.42
Sporulation and C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin. Microbiol Immunol (1978) 1.41
Intestinal absorption of botulinum toxins of different molecular sizes in rats. Infect Immun (1977) 1.41
Characterization of the immunoglobulin light chain variable region gene expressed in multiple myeloma. Leukemia (1998) 1.40
Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro. Oncogene (1999) 1.40
Nano DCPA-whisker composites with high strength and Ca and PO(4) release. J Dent Res (2006) 1.39
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum (1996) 1.39
ADP-ribosylation of the rho/rac proteins induces growth inhibition, neurite outgrowth and acetylcholine esterase in cultured PC-12 cells. Biochem Biophys Res Commun (1990) 1.38
Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components. Infect Immun (1981) 1.38
Successful treatment with cyclosporin A of pure red cell aplasia associated with rheumatoid arthritis. J Rheumatol (1996) 1.37
Diagnostic criteria for non-traumatic osteonecrosis of the femoral head. A multicentre study. J Bone Joint Surg Br (1999) 1.37
In vitro production of Clostridium perfringens enterotoxin and its detection by reversed passive hemagglutination. Appl Microbiol (1973) 1.36
Separation and determination of mugineic acid and its analogues by high-performance liquid chromatography. J Chromatogr (1987) 1.36
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia (1998) 1.35
A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells. Eur J Immunol (1998) 1.35
Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem (1999) 1.34
Identification of single C motif-1/lymphotactin receptor XCR1. J Biol Chem (1998) 1.31
Role of macrophages as modulators but not as stimulators in primary mixed leukocyte reaction. Cell Immunol (1984) 1.30
The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Infect Immun (1986) 1.30
New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene (1999) 1.30
Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum (1985) 1.29
Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology (1999) 1.29
Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin. Jpn J Med Sci Biol (1978) 1.29
Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol (2002) 1.28
Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502. Tissue Antigens (2007) 1.26